LOGIN
Etoricoxib and diclofenac similar for blood loss and GI distress rates after THA
May 2016
Etoricoxib and diclofenac similar for blood loss and GI distress rates after THA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Perioperative blood loss and gastrointestinal tolerability of etoricoxib and diclofenac in total hip arthroplasty (ETO-DIC study): a single-center, prospective, double-blinded randomized controlled trial
Curr Med Res Opin. 2016 Jan;32(1):37-47.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
100 patients scheduled for total hip arthroplasty were randomized to receive either etoricoxib or diclofenac sodium (for perioperative analgesic treatment) and evaluated for drug-associated blood loss and incidence of gastrointestinal distress. The purpose of this study was to evaluate if treatment with etoricoxib lead to better outcomes compared to diclofenac. Results of this study demonstrated t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.